Literature DB >> 26602759

[Catheter ablation of ventricular arrhythmias. Complications and emergency situations].

Kristina Wasmer1,2, Lars Eckardt3,4.   

Abstract

Catheter ablation of ventricular arrhythmias is an established treatment for patients with and without structural heart disease. For patients without structural heart disease, the aim is symptomatic relief, while the ultimate goals for patients with underlying structural heart disease are reduction of ICD therapies and improved prognosis. Rates for major complications range between 6-10% in patients with structural heart disease. Vascular complications are most common; life-threatening complications (e.g., pericardial tamponade and stroke) are less frequent. Procedure-associated mortality is reported to be 0-3%. In patients with idiopathic ventricular tachycardia, the complication rate is much lower compared to patients with structural heart disease.

Entities:  

Keywords:  Catheter ablation; Complications-management; Ventricular tachycardia

Mesh:

Year:  2015        PMID: 26602759     DOI: 10.1007/s00399-015-0403-5

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  31 in total

1.  EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).

Authors:  Etienne M Aliot; William G Stevenson; Jesus Ma Almendral-Garrote; Frank Bogun; C Hugh Calkins; Etienne Delacretaz; Paolo Della Bella; Gerhard Hindricks; Pierre Jaïs; Mark E Josephson; Josef Kautzner; G Neal Kay; Karl-Heinz Kuck; Bruce B Lerman; Francis Marchlinski; Vivek Reddy; Martin-Jan Schalij; Richard Schilling; Kyoko Soejima; David Wilber
Journal:  Europace       Date:  2009-05-14       Impact factor: 5.214

Review 2.  Transseptal catheterization: considerations and caveats.

Authors:  Stylianos Tzeis; George Andrikopoulos; Isabel Deisenhofer; Siew Yen Ho; George Theodorakis
Journal:  Pacing Clin Electrophysiol       Date:  2009-11-02       Impact factor: 1.976

3.  Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study.

Authors:  Borislav Dinov; Lukas Fiedler; Robert Schönbauer; Andreas Bollmann; Sascha Rolf; Christopher Piorkowski; Gerhard Hindricks; Arash Arya
Journal:  Circulation       Date:  2013-11-08       Impact factor: 29.690

4.  Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility.

Authors:  Sebastiaan R D Piers; Darryl P Leong; Carine F B van Huls van Taxis; Mohammad Tayyebi; Serge A Trines; Daniël A Pijnappels; Victoria Delgado; Martin J Schalij; Katja Zeppenfeld
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-04-25

5.  Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study.

Authors:  Hildegard Tanner; Gerhard Hindricks; Marius Volkmer; Steve Furniss; Volker Kühlkamp; Dominique Lacroix; Christian DE Chillou; Jesús Almendral; Domenico Caponi; Karl-Heinz Kuck; Hans Kottkamp
Journal:  J Cardiovasc Electrophysiol       Date:  2009-07-28

6.  Trans-septal catheterization in the electrophysiology laboratory: data from a multicenter survey spanning 12 years.

Authors:  Roberto De Ponti; Riccardo Cappato; Antonio Curnis; Paolo Della Bella; Luigi Padeletti; Antonio Raviele; Massimo Santini; Jorge A Salerno-Uriarte
Journal:  J Am Coll Cardiol       Date:  2006-02-09       Impact factor: 24.094

Review 7.  Venturing into ventricular arrhythmia storm: a systematic review and meta-analysis.

Authors:  Sachin Nayyar; Anand N Ganesan; Anthony G Brooks; Thomas Sullivan; Kurt C Roberts-Thomson; Prashanthan Sanders
Journal:  Eur Heart J       Date:  2012-12-21       Impact factor: 29.983

Review 8.  Ventricular arrhythmias in the absence of structural heart disease.

Authors:  Eric N Prystowsky; Benzy J Padanilam; Sandeep Joshi; Richard I Fogel
Journal:  J Am Coll Cardiol       Date:  2012-05-15       Impact factor: 24.094

9.  Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.

Authors:  Karl-Heinz Kuck; Anselm Schaumann; Lars Eckardt; Stephan Willems; Rodolfo Ventura; Etienne Delacrétaz; Heinz-Friedrich Pitschner; Josef Kautzner; Burghard Schumacher; Peter S Hansen
Journal:  Lancet       Date:  2010-01-02       Impact factor: 79.321

10.  Safety of ventricular tachycardia ablation in clinical practice: findings from 9699 hospital discharge records.

Authors:  David F Katz; Mintu P Turakhia; William H Sauer; Wendy S Tzou; Russell R Heath; Matthew M Zipse; Ryan G Aleong; Paul D Varosy; David P Kao
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-02-15
View more
  1 in total

Review 1.  [Updated ESC guideline: innovations for the treatment of ventricular arrhythmias and recommendations for prevention of sudden cardiac death].

Authors:  L Eckardt; T Deneke
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.